Thomas A MCCOURT Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Thomas A MCCOURT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Thomas A MCCOURT. Thomas A MCCOURT is Director in ACCELERON PHARMA INC ($XLRN) and Chief Commercial Officer in IRONWOOD PHARMACEUTICALS INC ($IRWD) and President in IRONWOOD PHARMACEUTICALS INC ($IRWD).
Latest Insider Trading Transactions of Thomas A MCCOURT
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 40.61 | 7,500 | 304,575 | 0 | |
| Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 121.23 | 200 | 24,246 | 6,044 | 6.2 K to 6 K (-3.20 %) |
| Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 120.16 | 1,143 | 137,343 | 6,244 | 7.4 K to 6.2 K (-15.47 %) |
| Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 119.36 | 4,030 | 481,021 | 7,387 | 11.4 K to 7.4 K (-35.30 %) |
| Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 118.39 | 2,127 | 251,816 | 11,417 | 13.5 K to 11.4 K (-15.70 %) |
| Apr 21 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 40.61 | 7,500 | 304,575 | 13,544 | 6 K to 13.5 K (+124.09 %) |
| Feb 24 2021 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Grant | A | 0.00 | 145,631 | 0 | 486,262 | 340.6 K to 486.3 K (+42.75 %) |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 115.53 | 3,222 | 372,238 | 3,222 | |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,622 | 0 | 6,044 | 4.4 K to 6 K (+36.68 %) |
| Dec 16 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | M | 9.89 | 99,988 | 988,881 | 0 | |
| Dec 16 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Payment of Exercise | F | 12.20 | 81,089 | 989,286 | 340,631 | 421.7 K to 340.6 K (-19.23 %) |
| Dec 16 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Buy | M | 9.89 | 99,988 | 988,881 | 421,720 | 321.7 K to 421.7 K (+31.08 %) |
| Dec 16 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | M | 9.89 | 99,988 | 988,881 | 0 | |
| Dec 16 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Payment of Exercise | F | 12.20 | 81,089 | 989,286 | 340,631 | 421.7 K to 340.6 K (-19.23 %) |
| Dec 16 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Buy | M | 9.89 | 99,988 | 988,881 | 421,720 | 321.7 K to 421.7 K (+31.08 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 30.17 | 3,272 | 98,716 | 0 | |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 32.98 | 20,000 | 659,600 | 0 | |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 91.38 | 200 | 18,276 | 4,422 | 4.6 K to 4.4 K (-4.33 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 90.64 | 13,896 | 1,259,533 | 4,622 | 18.5 K to 4.6 K (-75.04 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 89.98 | 9,176 | 825,656 | 18,518 | 27.7 K to 18.5 K (-33.13 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 30.17 | 3,272 | 98,716 | 27,694 | 24.4 K to 27.7 K (+13.40 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 32.98 | 20,000 | 659,600 | 24,422 | 4.4 K to 24.4 K (+452.28 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 30.17 | 3,272 | 98,716 | 0 | |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | M | 32.98 | 20,000 | 659,600 | 0 | |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 91.38 | 200 | 18,276 | 4,422 | 4.6 K to 4.4 K (-4.33 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 90.64 | 13,896 | 1,259,533 | 4,622 | 18.5 K to 4.6 K (-75.04 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Sell | S | 89.98 | 9,176 | 825,656 | 18,518 | 27.7 K to 18.5 K (-33.13 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 30.17 | 3,272 | 98,716 | 27,694 | 24.4 K to 27.7 K (+13.40 %) |
| Sep 15 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Buy | M | 32.98 | 20,000 | 659,600 | 24,422 | 4.4 K to 24.4 K (+452.28 %) |
| May 13 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Sell | S | 10.35 | 1,697 | 17,564 | 319,847 | 321.5 K to 319.8 K (-0.53 %) |
| Mar 02 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Grant | A | 0.00 | 100,482 | 0 | 321,544 | 221.1 K to 321.5 K (+45.45 %) |
| Feb 25 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Sell | S | 11.63 | 1,865 | 21,690 | 221,062 | 222.9 K to 221.1 K (-0.84 %) |
| Feb 25 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Sell | S | 11.63 | 2,312 | 26,889 | 222,927 | 225.2 K to 222.9 K (-1.03 %) |
| Jan 28 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | M | 10.02 | 20,000 | 200,400 | 0 | |
| Jan 28 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Sell | S | 12.71 | 20,000 | 254,200 | 225,239 | 245.2 K to 225.2 K (-8.16 %) |
| Jan 28 2020 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Buy | M | 10.02 | 20,000 | 200,400 | 245,239 | 225.2 K to 245.2 K (+8.88 %) |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,377 | 0 | 4,422 | 3 K to 4.4 K (+45.22 %) |
| Dec 18 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Grant | A | 0.00 | 115,220 | 0 | 224,959 | 109.7 K to 225 K (+104.99 %) |
| Sep 04 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | M | 4.88 | 130,000 | 634,400 | 0 | |
| Sep 04 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | M | 4.88 | 90,000 | 439,200 | 44,944 | |
| Sep 04 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Sell | S | 9.24 | 220,000 | 2,032,800 | 109,739 | 329.7 K to 109.7 K (-66.72 %) |
| Sep 04 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Buy | M | 4.88 | 130,000 | 634,400 | 329,739 | 199.7 K to 329.7 K (+65.08 %) |
| Sep 04 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Buy | M | 4.88 | 90,000 | 439,200 | 199,739 | 109.7 K to 199.7 K (+82.01 %) |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 12.56 | 504 | 6,330 | 80,504 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 11.65 | 962 | 11,207 | 110,962 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 13.11 | 971 | 12,730 | 95,971 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 9.89 | 4,988 | 49,331 | 99,988 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 4.88 | 4,944 | 24,127 | 134,944 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 11.49 | 39,982 | 459,393 | 384,982 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 12.95 | 11,154 | 144,444 | 142,404 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 14.93 | 8,518 | 127,174 | 166,018 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Option Exercise | A | 9.12 | 4,056 | 36,991 | 179,056 | |
| Apr 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | President | Grant | A | 0.00 | 5,133 | 0 | 88,442 | 83.3 K to 88.4 K (+6.16 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.32 | 14 | 200 | 83,309 | 83.3 K to 83.3 K (-0.02 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.32 | 17 | 243 | 83,323 | 83.3 K to 83.3 K (-0.02 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.32 | 10 | 143 | 83,340 | 83.4 K to 83.3 K (-0.01 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.31 | 1,631 | 23,340 | 83,350 | 85 K to 83.4 K (-1.92 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.31 | 1,957 | 28,005 | 84,981 | 86.9 K to 85 K (-2.25 %) |
| Feb 22 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.31 | 1,212 | 17,344 | 86,938 | 88.2 K to 86.9 K (-1.37 %) |
| Jan 31 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 12.90 | 345,000 | 4,450,500 | 345,000 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,250 | 0 | 3,045 | 1.8 K to 3 K (+69.64 %) |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | J | 5.48 | 130,000 | 712,400 | 130,000 | |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | J | 5.48 | 130,000 | 712,400 | 0 | |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | J | 5.48 | 130,000 | 712,400 | 130,000 | |
| Jan 03 2019 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | J | 5.48 | 130,000 | 712,400 | 0 | |
| Aug 02 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 88,150 | 76.2 K to 88.2 K (+15.76 %) |
| Jul 10 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | M | 5.48 | 30,000 | 164,400 | 130,000 | |
| Jul 10 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 20.00 | 30,000 | 600,000 | 0 | 30 K to 0 (-100.00 %) |
| Jul 10 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Buy | M | 5.48 | 30,000 | 164,400 | 30,000 | 0 to 30 K |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 40.61 | 7,500 | 304,575 | 7,500 | |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 1,250 | 0 | 1,795 | 545 to 1.8 K (+229.36 %) |
| Feb 22 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 14.55 | 131,250 | 1,909,688 | 131,250 | |
| Feb 22 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Grant | A | 0.00 | 21,875 | 0 | 74,513 | 52.6 K to 74.5 K (+41.56 %) |
| Feb 22 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.66 | 1,917 | 28,103 | 52,638 | 54.6 K to 52.6 K (-3.51 %) |
| Feb 22 2018 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 14.66 | 1,426 | 20,905 | 54,555 | 56 K to 54.6 K (-2.55 %) |
| May 16 2017 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | M | 5.48 | 30,000 | 164,400 | 130,000 | |
| May 16 2017 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 18.20 | 30,000 | 546,000 | 0 | 30 K to 0 (-100.00 %) |
| May 16 2017 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Buy | M | 5.48 | 30,000 | 164,400 | 30,000 | 0 to 30 K |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 30.17 | 3,272 | 98,716 | 3,272 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Grant | A | 0.00 | 545 | 0 | 545 | 0 to 545 |
| Mar 01 2017 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 16.77 | 157,500 | 2,641,275 | 157,500 | |
| Mar 01 2017 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Grant | A | 0.00 | 26,250 | 0 | 54,300 | 28.1 K to 54.3 K (+93.58 %) |
| Feb 24 2017 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 16.94 | 1,520 | 25,749 | 28,050 | 29.6 K to 28.1 K (-5.14 %) |
| Jul 25 2016 | XLRN | ACCELERON PHARMA I ... | MCCOURT Thomas A | Director | Option Exercise | A | 32.98 | 20,000 | 659,600 | 20,000 | |
| Mar 03 2016 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 10.24 | 175,000 | 1,792,000 | 175,000 | |
| Feb 26 2016 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Sell | S | 8.50 | 1,600 | 13,600 | 27,312 | 28.9 K to 27.3 K (-5.53 %) |
| Mar 18 2015 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 15.62 | 97,500 | 1,522,950 | 97,500 | |
| Mar 18 2015 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Grant | A | 0.00 | 16,250 | 0 | 27,298 | 11 K to 27.3 K (+147.09 %) |
| Feb 04 2010 | IRWD | IRONWOOD PHARMACEU ... | MCCOURT Thomas A | Chief Commercial Of ... | Option Exercise | A | 11.25 | 20,000 | 225,000 | 20,000 |
Page: 1